Pierre-Yves Berclaz, Chief Science and Medical Officer at Ferring Pharmaceuticals, stated: "The ADAPT-1 trial results confirm the efficacy and safety of follitropin delta across the full range of ...

Data presented today at the ESHRE congress builds evidence for conventional-based Follicular Stimulating Hormone (FSH) dosing for Rekovelle (follitropin delta); alongside its existing unique algorithm ...

The ADAPT-1 trial was a multicentre, randomised, assessor-blind study involving 300 women aged 18-40 years undergoing IVF or ICSI. 3 The trial compared the efficacy and safety of follitropin delta ...

These data build on previous studies which have established an estimated point of clinical correspondence for 10 µg follitropin delta to 150 IU follitropin alfa in this class of medications. 1,2 ...

Major insurance changes are coming to GLP-1 drugs for weight loss. Here’s what to know ...

As Direct Meds continues its growth trajectory, the company remains committed to using AI to scale care delivery while preserving the personal, nurse-supported experience it’s known for.

President Trump signed an executive order aiming to cut prescription drug costs by bringing the price the U.S. pays in line with comparable developed nations.

Discover how a 5-day fasting-mimicking diet revolutionizes type 2 diabetes management, reducing medications and improving blood sugar control naturally.